ImmuCell Corporation (ICCC): Price and Financial Metrics
Today's Latest Price: $6.00 USD
Nov 27 12:49pm Add ICCC to Watchlist Sign Up
ICCC Stock Summary ICCC has a higher market value than only 12.72% of US stocks; more precisely, its current market capitalization is $42,123,447. Price to trailing twelve month operating cash flow for ICCC is currently 37.86, higher than 89.01% of US stocks with positive operating cash flow. Equity multiplier, or assets relative to shareholders' equity, comes in at 1.39 for Immucell Corp; that's greater than it is for only 20.2% of US stocks. Stocks with similar financial metrics, market capitalization, and price volatility to Immucell Corp are OIIM, MOSY, APVO, ADTN, and RIGL. ICCC's SEC filings can be seen here. And to visit Immucell Corp's official web site, go to immucell.com.
ICCC Price/Volume Stats
ICCC Latest News Stream
All News Types
Loading, please wait...
Latest ICCC News From Around the Web
Below are the latest news stories about Immucell Corp that investors may wish to consider to help them evaluate ICCC as an investment opportunity.
The following slide deck was published by ImmuCell Corporation in conjunction with their 2020 Q2 earnings call....
The bovine health products maker reported sales of $3 million and a net loss of $766,000 for the quarter ending June 30.
ImmuCell (ICCC): Q2 GAAP EPS of -$0.11 misses by $0.01.Revenue of $2.97M (+9.6% Y/Y) misses by $0.03M."We reduced the backlog of orders to ~$945K as of June 30, 2020 from ~$1.4M as of March 31, 2020. The investment to increase our First Defense production capacity remains on budget and close to...
PORTLAND, Maine, Aug. 12, 2020 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company…
Conference Call Scheduled for Thursday, August 13, 2020 at 9:00 AM ET
Read More 'ICCC' Stories Here
ICCC Price Returns
Get Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!
Page generated in 0.7649 seconds.